CAPS Medical

Selective Minimally Invasive Treatment of Solid Tumors

Health Tech & Life Sciences
Active
Series A Netanya, Israel Founded 2018
Last updated 2026-06-18
Total raised
$8.3M
Last: 2020-08
Stage
Series A
Founded
2018
Headcount
17
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences

About

CAPS Medical is a medical device company focused on the development and commercialization of its NTAP System, which uses non-thermal atmospheric plasma (NTAP) to treat a wide range of solid tumors. The minimally invasive and selective cancer treatment targets solid tumors and aims to selectively and precisely destroy only cancerous cells, leaving healthy tissue intact.

The company has obtained outstanding results from its first clinical study focusing on non-muscle invasive bladder cancer (NMIBC), the sixth most common cancer . Worldwide, more than 1.6 M people suffer from NMIBC, with around 200,000 new cases annually. In addition the company has demonstrated feasibility to enable the technology’s use for additional cancers including in lungs, esophagus, stomach ,GI and others.

Originally developed at the Technion - Israel Institute of Technology, the system is supported by key opinion leaders from medical fields such as oncology and interventional radiology. CAPS Medical has been supported by major shareholders and a strategic investo.

Funding history · 2 rounds · $8.3M total

Q&A

What is CAPS Medical's primary focus?
CAPS Medical is a medical device company focused on developing and commercializing its NTAP System, which uses non-thermal atmospheric plasma to treat a wide range of solid tumors.
When was CAPS Medical founded?
CAPS Medical was founded in December 2018.
What is the current employee count for CAPS Medical?
CAPS Medical has 17 employees, falling within the 11-50 employee bucket.
What is the total amount of funding CAPS Medical has raised to date?
CAPS Medical has raised a total of $8,300,000.
Which investors participated in CAPS Medical's July 2020 funding round?
In July 2020, CAPS Medical received funding from Israel Investment Fund Group and Chasing Value Asset Management.
What is CAPS Medical's current funding stage?
CAPS Medical is currently in its Series A funding stage.
Where is CAPS Medical headquartered?
CAPS Medical is headquartered in Netanya, Center District, Israel.
What is the core technology behind CAPS Medical's treatment system?
The core technology is the NTAP System, which utilizes non-thermal atmospheric plasma to selectively destroy cancerous cells while preserving healthy tissue.

Team · 1

Founder · Co-founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B2C

Highlights

1 PatentsVerified

Tags

drug-deliverycancerminimally-invasivetreatmentscathetersmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)